Abstract:Protein arginine methyltransferase 1 (PRMT1) and co‐activator‐associated arginine methyltransferase 1 (CARM1) are critical components of a diverse set of intracellular functions including cell signaling and transcriptional regulation. Despite the limited number of studies investigating PRMT biology in muscle, evidence strongly suggests that PRMT1 and CARM1 are important players in the regulation of skeletal muscle plasticity. However, their role in disuse‐induced muscle remodeling is unknown. Thus, our study objective was to determine whether denervation‐induced muscle disuse alters PRMT expression and activity in skeletal muscle and to contextualize PRMT biology within the early disuse‐evoked signaling events that precede muscle atrophy. After unilateral sectioning of the sciatic nerve, mice were subjected to 6 (n = 7), 12 (n = 7), 24 (n = 6), 72 (n = 5), or 168 (n = 4) hours of denervation. The contralateral limb served as an internal control. Western blot analyses were employed to determine protein expression levels in the denervated tibialis anterior (TA) muscle, relative to the contralateral, non‐denervated, control TA muscle across the experimental time course. A ~25% reduction (p < 0.05) in TA muscle mass was observed in the denervated hind limb after 168 hours. PRMT1 and CARM1 protein expression were significantly increased by 3‐ and 1.3‐fold, respectively, in the denervated hind limb, as compared to the control limb after 72 and 168 hours of inactivity. This differential response to denervation‐induced muscle disuse suggests a unique sensitivity to, or regulation by, potential upstream signaling and transcriptional pathways. These denervation‐induced increases in PRMT expression were accompanied by a ~15–25% elevation in cellular mono‐methyl arginine content at 72 and 168 hours, a marker of global PRMT methyltransferase activity. Muscle RING‐finger protein‐1 (MuRF1) protein expression was also significantly elevated 2.5–3‐fold after 72 and 168 hours of denervation, suggesting that PRMT expression may be mediated by factors governing the muscle atrophy program. Peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α) protein expression was diminished by ~40% (p < 0.05) in the denervated limb after 6 hours and remained depressed throughout the time course. In contrast, p38 mitogen‐activated protein kinase (MAPK) phosphorylation status (phosphorylated/total) tended to be elevated by ~10–50% in the denervated muscle throughout the experimental time course. AMP‐activated protein kinase (AMPK) phosphorylation status was lowered by ~40% (p < 0.05) after 6 and 12 hours of denervation. By 168 hours, AMPK phosphorylation status was 50% greater in the denervated limb than in the control limb. Our data suggest that alterations in AMPK, p38 MAPK, and PGC‐1α signaling are among the earliest signals that precede the induction of the atrophy program in response to neurogenic muscle disuse. Furthermore, PRMT1 and CARM1 may contribute to the remodeling of muscle during denervation‐induced atrophy. Support or Funding Information Natural Sciences and Engineering Research Council of Canada and Canada Research Chairs

Skeletal muscle atrophy after sciatic nerve damage: Mechanistic insights

PI3 Kinase Regulation of Neural Regeneration and Muscle Hypertrophy after Spinal Cord Injury

Microarray Analysis of Gene Expression Provides New Insights Into Denervation-Induced Skeletal Muscle Atrophy

Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review

Pathophysiological Aspects of Muscle Atrophy and Osteopenia Induced by Chronic Constriction Injury (CCI) of the Sciatic Nerve in Rats

Effect of Denervation on XBP1 in Skeletal Muscle and the Neuromuscular Junction

Pharmacologic approaches to prevent skeletal muscle atrophy after spinal cord injury

Myokines in Home-Based Functional Electrical Stimulation-Induced Recovery of Skeletal Muscle in Elderly and Permanent Denervation

Cellular and molecular mechanisms of muscle atrophy

Mtorc1 and PKB/Akt Control the Muscle Response to Denervation by Regulating Autophagy and HDAC4.

Muscle Atrophy and mRNA-miRNA Network Analysis of Vascular Endothelial Growth Factor (VEGF) in a Mouse Model of Denervation-Induced Disuse

Utilization of the Rat Tibial Nerve Transection Model to Evaluate Cellular and Molecular Mechanisms Underpinning Denervation-Mediated Muscle Injury

Protein Arginine Methyltransferase Expression During An Acute Time Course Of Denervation‐Induced Skeletal Muscle Plasticity

[Experimental Study of Morphology and Electrophysiology on Denervated Skeletal Muscle].

mTORC1 mediates fiber type-specific regulation of protein synthesis and muscle size during denervation

Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action

Skeletal muscle atrophy: From mechanisms to treatments

Skeletal muscle immobilisation-induced atrophy: mechanistic insights from human studies

Changes of Gene Expression Patterns of Muscle Pathophysiology-Related Transcription Factors During Denervated Muscle Atrophy

Critical Limb Ischemia Induces Remodeling of Skeletal Muscle Motor Unit and Myonuclear- and Mitochondrial-Domains

Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy